Guardant Health
GH
#3559
Rank
NZ$4.98 B
Marketcap
$40.55
Share price
-1.18%
Change (1 day)
-12.26%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of June 2024 : -NZ$2.61 M

According to Guardant Health 's latest financial reports the company has -NZ$2.61 M in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$0.25 B164.72%
2022-12-31$NZ$94.78 M-89.94%
2021-12-31$NZ$0.94 B-50.03%
2020-12-31$NZ$1.88 B49.94%
2019-12-31$NZ$1.25 B60.7%
2018-12-31$NZ$0.78 B80.02%
2017-12-31$NZ$0.43 B277.68%
2016-12-31$NZ$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$1.35 B-51,961.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.08 B-195,024.98%๐Ÿ‡บ๐Ÿ‡ธ USA